Remove 2005 Remove Concentrates Remove Safety Remove Sativa
article thumbnail

ElleVet Sciences Publishes Safety Study On CBD For Animals

Cannabis Law Report

ElleVet Sciences is pleased to announce the results and publication of the first safety study on the use of hemp CBD/CBDA. The 12-week safety study, conducted by Dr. Joseph Wakshlag, DVM, Ph.D., Dr. Wakshlag is currently available for interviews to discuss the results of the safety study as well as his clinical trials.

Safety 45
article thumbnail

What are cannabis chemovars and chemotypes?

The Cannigma

Researchers conducting survey based studies today often only have access to the THC concentration of the cannabis that their participants are using. Other species with several chemotypes include peppermint, lavender, rosemary, basil, and of course, Cannabis sativa. Type III: CBD dominant with low concentrations of THC and/or CBG.

Terpenes 138
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Understanding the Background of Medical Marijuana Laws in Los Angeles

The Joint Blog

From the 1st of January, 2018, it became legal to buy, carry, use, and grow cannabis sativa without a valid physician’s recommendation. Supreme Court Ruling of 2005 – Federal Prosecution Possible. 2016’s Massive Step Forward with the Medical Marijuana Regulation and Safety Act. Up to six plants were also allowed to growers.

Law 36
article thumbnail

Italy: MINISTRY OF HEALTH DECREE – Definition of maximum levels of tetrahydrocannabinol (THC) in food

Cannabis Law Report

the European Food Safety Authority and establishes procedures in the. food safety; Having regard to Regulation (EC) no. 1290/2005 and (CE) n. use in the areas of human nutrition; Having regard to the opinion of EFSA (European Safety Authority. food): «Scientific Opinion on the safety of hemp (Cannabis. 178/2002 no.

Food 45
article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Framings that more often carried a negative tone were related to poor evidence and safety issues.